Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | HSD11B1 | P28845 | 9/20 | 0.58 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | HTR7 | P34969 | 1/20 | 0.51 |
| ▸ | HTR6 | P50406 | 1/20 | 0.51 |
| ▸ | MGLL | Q99685 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL224933 | 0.98 | MEN1 (0.70) | MEN1CYP2D6KMT2AHSD11B1HTR2A | |
| Bromide SCHEMBL7253785 | 0.98 | MEN1 (0.65) | MEN1CYP2D6KMT2AHSD11B1HTR2A | |
| SCHEMBL8110383 | 0.93 | MEN1 (0.59) | MEN1CYP2D6KMT2AHSD11B1HTR2A | |
| Bromide SCHEMBL9092341 | 0.92 | MEN1 (0.58) | MEN1CYP2D6KMT2AHSD11B1HTR2A | |
| Trifluoroacetic Acid SCHEMBL252584 | 0.91 | MEN1 (0.56) | MEN1CYP2D6KMT2AHSD11B1 | |
| SCHEMBL2146518 | 0.89 | MEN1 (0.54) | MEN1CYP2D6KMT2AHSD11B1HTR2A | |
| Hydrochloric Acid SCHEMBL5478246 | 0.88 | MEN1 (0.57) | MEN1CYP2D6KMT2AHSD11B1HTR2A | |
| Hydrochloric Acid SCHEMBL5478248 | 0.88 | MEN1 (0.57) | MEN1CYP2D6KMT2AHSD11B1HTR2A | |
| SCHEMBL31164032 | 0.86 | HSD11B1 (0.68) | HSD11B1HTR2AHTR2CHTR7HTR6 | |
| SCHEMBL662115 | 0.86 | HSD11B1 (0.68) | HSD11B1HTR2AHTR2CHTR7HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 609 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118561742-A | Rupestonic acid amide derivative containing nitrogen heterocycle, and preparation method and application thereof | 中国科学院新疆理化技术研究所 | 2024-08-30 | — | — | CN | claimed |
| CN-108033694-A | Novel silicate cement and preparation method thereof | 天津山水水泥有限公司 | 2018-05-15 | — | — | CN | claimed |
| CN-106866625-A | The preparation method of ketanserin | 上海鼎雅药物化学科技有限公司 | 2017-06-20 | — | — | CN | claimed |
| CN-1793138-B | Process for prepering aspetllinone | BOSU MEDICINE SCI & TECH CO LTD SHANGHAI | 2010-05-12 | — | — | CN | claimed |
| JP-2006516587-A | — | — | 2006-07-06 | — | — | JP | claimed |
| CN-1793138-A | Process for prepering aspetllinone | BOSU MEDICINE SCI & TECH CO LT (CN) | 2006-06-28 | — | — | CN | claimed |
| EP-1599204-A2 | SELECTIVE MGLU5 ANTAGONISTS FOR TREATMENT OF NEUROMUSCULAR DYSFUNCTION OF THE LOWER URINARY TRACT | Recordati Ireland Limited (IE) | 2005-11-30 | — | — | EP | claimed |
| US-6841550-B1 | Benzoxazine and benzothiazine derivatives and their use in medicines | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-01-11 | — | — | US | claimed |
| WO-2004067002-A2 | SELECTIVE mGlu5 ANTAGONISTS FOR TREATMENT OF NEUROMUSCULAR DYSFUNCTION OF THE LOWER URINARY TRACT | RECORDATI IRELAND LIMITED (IE) | 2004-08-12 | — | — | WO | claimed |
| EP-1114037-B1 | BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN MEDICINES | SCHERING AG (DE) | 2004-05-12 | — | — | EP | claimed |
| US-5643927-A | METHOD OF PREPARATION BY DEHYDROCHLORINATION BETWEEN 4-(P-FLUOROBENZOYLPIPERIDINE WITH CHLOROALKYLCHROMEN-4-ONE | FERRER INTERNACIONAL, S.A. (ES) | 1997-07-01 | — | — | US | claimed |
| WO-1997010238-A1 | QUINOLEIN-2(1H)-ONE DERIVATIVES AS SEROTONIN ANTAGONISTS | SYNTHELABO (FR) | 1997-03-20 | — | — | WO | claimed |
| JP-H08510478-A | — | — | 1996-11-05 | — | — | JP | claimed |
| EP-0699197-A1 | 4-P-FLUOROBENZOYL-1-PIPERIDINYL-PROPOXY-CHROMEN-4-ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF PSYCHOSIS AND SCHIZOPHRENIA | FERRER INTERNACIONAL, S.A. (ES) | 1996-03-06 | — | — | EP | claimed |
| WO-1995025733-A1 | 4-P-FLUOROBENZOYL-1-PIPERIDINYL-PROPOXY-CHROMEN-4-ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF PSYCHOSIS AND SCHIZOPHRENIA | FERRER INTERNACIONAL, S.A. (ES) | 1995-09-28 | — | — | WO | claimed |
| EP-0433149-B1 | Serotonin antagonists, their preparation and pharmaceuticals containing them | RHONE POULENC SANTE (FR) | 1994-02-16 | — | — | EP | claimed |
| EP-0070053-B1 | NOVEL BICYCLIC PYRIMIDIN-5-ONE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1986-04-16 | — | — | EP | claimed |
| EP-0098499-A1 | Process for preparing ketanserine | RAVIZZA S.p.A. (IT) | 1984-01-18 | — | — | EP | claimed |
| EP-0070053-A2 | Novel bicyclic pyrimidin-5-one derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1983-01-19 | — | — | EP | claimed |
| EP-0046179-A1 | 3-(3-(4-(4-Fluorobenzoyl)piperidyl)propyl)-2-methyl indole and pharmaceutical composition containing it | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1982-02-24 | — | — | EP | claimed |